4//SEC Filing
THERASENSE INC 4
Accession 0001267399-04-000032
CIK 0001073695operating
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 2:38 PM ET
Size
25.2 KB
Accession
0001267399-04-000032
Insider Transaction Report
Form 4
THERASENSE INCTHER
TATRO MARK C
VP of Finance
Transactions
- Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−4,382$118,314→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$19.91/sh−8,750$174,213→ 0 totalExercise: $7.09From: 1988-08-08Exp: 2013-02-25→ Common Stock (8,750 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$23.00/sh−375$8,625→ 0 totalExercise: $4.00From: 1988-08-08Exp: 2010-07-31→ Common Stock (375 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$6.51/sh−10,000$65,100→ 0 totalExercise: $20.49From: 1988-08-08Exp: 2012-01-29→ Common Stock (10,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$18.00/sh−8,500$153,000→ 0 totalExercise: $9.00From: 1988-08-08Exp: 2011-08-03→ Common Stock (8,500 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$6.80/sh−20,978$142,650→ 0 totalExercise: $20.20From: 1988-08-08Exp: 2014-01-05→ Common Stock (20,978 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$17.20/sh−40,000$688,000→ 0 totalExercise: $9.80From: 1988-08-08Exp: 2012-12-13→ Common Stock (40,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$23.50/sh−42,500$998,750→ 0 totalExercise: $3.50From: 1988-08-08Exp: 2010-06-16→ Common Stock (42,500 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$3.20/sh−80,000$256,000→ 0 totalExercise: $23.80From: 1988-08-08Exp: 2011-12-14→ Common Stock (80,000 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to a merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories.
- [F2]This option provided for vesting over a four year period and was cancelled pursuant to the merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
- [F3]Includes 871 shares acquired under the TheraSense, Inc. Employee Stock Purchase Plan on April 2, 2004.
Documents
Issuer
THERASENSE INC
CIK 0001073695
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001073695
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 2:38 PM ET
- Size
- 25.2 KB